Annual Report

Date: 18.08.2026 BSE Limited Phiroze Jeejeebhoy Towers, Dalal Street Mumbai – 400001 Dear Sir/Madam, Scrip Code: 524572 | Scrip ID: PHARMAID | ISIN: INE117D01018 Sub: Notice of Convening the 37th Annual General Meeting (“AGM”) and the Annual Report for the Financial Year 2025-2026. Pursuant to Regulation 34(1) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“Listing Regulations”), we enclose herewith the following for your information and records: 1. Notice of 37th Annual General Meeting scheduled to be held on Friday, September 11, 2026, at 12:00 noon (IST). 2. Copy of Annual Report for Financial Year 2025-2026. The Annual Report of the Company for the Financial Year 2025-26 along with Notice convening the AGM has been sent only through E-mail to all those Members whose E-mail addresses are registered with the Company or with their respective Depository Participant(s) (DP). Further, in accordance with Regulation 36(1)(b) of the Listing Regulations, a letter containing the web-link and path for accessing the Annual Report for FY 2025-26 is being sent to all those Members who have not registered their email ids with the Company/RTA/DPs. The aforesaid documents will also be available on the website of the Company at www.pharmaids.com In terms of Section 108 of the Companies Act, 2013 read with Rule 20 of the Companies (Management and Administration) Rules, 2014 as substituted by the Companies (Management and Administration) Amendment Rules, 2015 (‘the Rules’) and Regulation 44 of the Securities Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Company is providing the Remote E-Voting Facility to the Members to cast their vote by electronic means on all the Business items forming part of the Notice of the AGM. The Company has engaged services of Central Depository Service (India) Limited (CDSL) for providing E-Voting facility. PHARMAIDS PHARMACEUTICALS LIMITED (CIN: L52520KA1989PLC173979) Registered Office.: Unit #201, Brigade Rubix, 20/14, HMT Factory Road, Peenya Plantation, Bangalore 560013 INDIA Phone: 080-49784319 Email: compliance@pharmaids.com WEB: www.pharmaids.com The details pursuant to the provisions of the Companies Act 2013 and the Rules are given here under: Events Day and Date Cut-off date Friday 04, September 2026 E-voting Commencement date Tuesday 08, September 2026 E-voting end date Thursday 10, September 2026 Remote e-voting will be disabled by the RTA upon the expiry of the aforesaid period. Members are requested to refer to the detailed procedure for Remote E-Voting / E-Voting at AGM as provided in the Notice of 37th Annual General Meeting. This is for your kind information and record. Thanking you For Pharmaids Pharmaceuticals Limited Prasanna Subramanya Bhat (Company Secretary & Compliance Officer) PHARMAIDS PHARMACEUTICALS LIMITED (CIN: L52520KA1989PLC173979) Registered Office.: Unit #201, Brigade Rubix, 20/14, HMT Factory Road, Peenya Plantation, Bangalore 560013 INDIA Phone: 080-49784319 Email: compliance@pharmaids.com WEB: www.pharmaids.com ANNUAL REPORT 2025 ‑ 26 PHARMAIDS PHARMACEUTICALS LIMITED 37th Annual Report PHARMAIDS PHARMACEUTICALS LIMITED CIN:L52520KA1989PLC173979 CORPORATE INFORMATION BOARD OF DIRECTORS Mr. Pattamadai Natarajasarma Vijay Chairman (Independent Director) Dr. Shankarappa Nagaraja Vinaya Babu Vice Chairman (Non-Executive and Non-Independent Director) Mr. Shreedhara Shetty Non-Executive and Non-Independent Director Dr. Yogananda Moolemath Independent Director Mr. Methuku Nagesh Independent Director Mr. Venu Madhava Kaparthy Executive Director Ms. Mini Manikantan Executive Director CHIEF FINANCIAL OFFICER Mr. Balagangadhara B C COMPANY SECRETARY & COMPLIANCE OFFICER SECRETARIAL AUDITOR Mr. Prasanna Subramanya Bhat M/s Kashinath Sahu & Co, Mem No.- A48828 Practising Company Secretaries Hyderabad STATUTORY AUDITOR INTERNAL AUDITOR M/s PPKG & Co. T N Raghavendra Chartered Accountants Chartered Accountant Hyderabad Tumkur, Karnataka REGISTRAR & SHARE TRANSFER AGENT BANKERS M/s Venture Capital and Corporate Investments Pvt Ltd. Canara Bank “Aurum”, Door No.4-50/P-II/57/4F &5F, Plot No. 57, 4th ICICI Bank & 5th floors, Jayabheri Enclave Phase- II, Gachibowli Axis Bank Hyderabad – 500032 LISTING Phone No. 404-23818475, 23868275, 35164940 BSE Limited Website - www.vccipl.com Security code-524572 REGISTERED OFFICE SUBSIDIARIES Unit #201, 2nd Floor, Brigade Rubix, 20/14, HMT Factory Adita Bio Sys Private Limited Main Road, Peenya Plantation, Bangalore - 560013 Spring Labs (firm) Karnataka, India Telephone No.- 080- 49784319 Email- Id - compliance@pharmaids.com Website – www.pharmaids.com INDEX S.No. Contents Page No. 1. About this Report 3 2. About Pharmaids 4 3. Board’s Report 5 4. Annexures to Board’s Report 22 5. Management Discussion and Analysis Report 38 6. Corporate Governance Report 41 7. Annexures to Corporate Governance Report 61 8. Standalone Financial Statements 9. Independent Auditors’ Report 65 10. Balance sheet 76 11. Statement of P&L, Cash Flow & Changes in Equity 78 12. Notes to Standalone Financial Statements 83 13. Consolidated Financial Statements 14. Independent Auditors’ Report 121 15. Balance sheet 129 16. Statement of P&L, Cash Flow & Changes in Equity 131 17. Notes to Consolidated Financial Statements 137 18. Notice of 37th Annual General Meeting 176 About this report We are pleased to present the Thirty-Seventh Annual Report, for the financial year 2025-26. This report provides an overview of your Company’s operations, financial and non-financial performance during the year. Further, in this report, we have highlighted the key opportunities and challenges faced by our industry, as well as our policies and procedures for ensuring compliance and good governance. The report aims to provide a detailed insight into our financial and non-financial disclosures, encompassing our leadership, culture, and value creation strategy for stakeholders. Responsibility statement The Board firmly believes that this report is a fair representation of your Company’s financial, non- financial and operational performance and addresses all material topics relevant to the company for FY 2025-26. The Board acknowledges that contents of this report have been prepared by respective functions and under the guidance of the management. Certain statements in this report concerning our future growth prospects are forward-looking statements, which involve a number of risks, and uncertainties that could cause actual results to differ materially from those in such forward-looking statements due to risks or uncertainties associated with our expectations with respect to, but not limited to, our ability to successfully implement our strategy and our growth and expansion plans, technological changes, our exposure to market risks, general economic and political conditions in India which have an impact on our business activities or investments, changes in the laws and regulations that apply to the industry in which the Company operates. The Company does not undertake to update any forward-looking statements that may be made from time to time by or on behalf of the Company. About Pharmaids Incorporated in March 1989, we are a Public Limited Company listed on BSE Ltd since 1994. The new promoters, namely Dr. Shankarappa Nagaraja Vinaya Babu and Tumkur Trade Center Private Limited, came on board with effect from 17th September, 2025. With a unique business strategy, a modest investment plan and with a bold vision to be a global player in this business, we strive to provide high quality innovation and research, development, and manufacturing services to our partners. We have onboarded a team having thorough scientific, management and operational experience. We have also been able to bring in Independent Board members with excellent & longstanding experience. The Company and our subsidiaries work for clients around [Showing first 8,000 characters — download PDF for full document]